AZILECT Reviews (RASAGILINE MESYLATE)Average Rating: 3.0 (4 Ratings)Filter ResultsCompare AZILECT with similar:
Type: Rx Drug
|
Results are sorted by Gender with females listed first (reviews with no gender reported listed before females). Key to Ratings: 1=LOW (I would not recommend taking this medicine.) Page: 1 |
RATING | REASON | SIDE EFFECTS FOR AZILECT | COMMENTS | SEX | AGE | DURATION/ DOSAGE | DATE ADDED |
5 | Young Onset Parkinson's | Dry mouth, some dizziness. | Since taking Azilect my tremors and muscle stiffness have not worsened. It's set a floor under the progress of the disease for now. My biggest concerns with this drug focus on the interaction risks (see drugs.com for the lengthy list), including mandatory avoidance of pseudoephedrine, other cold medicines, and general anesthesia. | M | 46 | 2 years 1 mg 1X day | 8/24/2011 | 3 | Parkinson's | Good even got some smell back that I had lost years ago but managing medications when it interacts with so many other medications is difficult | M | 68 | 1 days 1 | 11/24/2015 | 2 | Young Onset Parkinson's | No side effects | It just didn't work for me. No relief from sympyoms. My PD symptoms have continued to worsen, albeit at a very slow pace. | M | 45 | 12 months 1 mg 1X day | 11/21/2010 | 2 | Parkinsons | None | I'm taking Azilect with Mirapex and Sinemet so don't know if it works or not. My insurance changed and now this drug costs over $300 a month. Just can't afford it since there is no generic. | M | 59 | 6 months 0.5 mg 1X day | 2/19/2011 |
AZILECT (RASAGILINE MESYLATE): Rasagiline is used alone or with other medications (such as levodopa/carbidopa) to treat symptoms of Parkinson's disease. It can help improve symptoms such as shakiness, stiffness, and difficulty moving. It can also help reduce the amount of "off" time (periods of slow movement or stiffness). Rasagiline belongs to a class of drugs known as MAO inhibitors. It works by increasing the levels of certain natural substances in the brain (such as dopamine, norepinephrine, serotonin). Parkinson's disease is thought to be caused by too little dopamine in the brain. FDA Approval Date: 2006-05-16 (Sources: U.S. Centers for Medicare Services, FDA)